These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34303327)

  • 1. pH-Sensitive Polymer-Based Carriers as a Useful Approach for Oral Delivery of Therapeutic Protein: A Review.
    Lori MS; Ohadi M; Estabragh MAR; Afsharipour S; Banat IM; Dehghannoudeh G
    Protein Pept Lett; 2021; 28(11):1230-1237. PubMed ID: 34303327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances and applications of chitosan-based nanomaterials as oral delivery carriers: A review.
    Lang X; Wang T; Sun M; Chen X; Liu Y
    Int J Biol Macromol; 2020 Jul; 154():433-445. PubMed ID: 32194103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics.
    Zheng AP; Wang JC; Lu WL; Zhang X; Zhang H; Wang XQ; Zhang Q
    J Nanosci Nanotechnol; 2006; 6(9-10):2936-44. PubMed ID: 17048501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design of pH-sensitive chitosan-based formulations for gastrointestinal delivery.
    Du H; Liu M; Yang X; Zhai G
    Drug Discov Today; 2015 Aug; 20(8):1004-11. PubMed ID: 25769687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs.
    Lin YH; Liang HF; Chung CK; Chen MC; Sung HW
    Biomaterials; 2005 May; 26(14):2105-13. PubMed ID: 15576185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
    George M; Abraham TE
    J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
    Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel pH-sensitive nanoparticles loaded hydrogel for transdermal drug delivery.
    Qindeel M; Ahmed N; Sabir F; Khan S; Ur-Rehman A
    Drug Dev Ind Pharm; 2019 Apr; 45(4):629-641. PubMed ID: 30633578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLSM method for the dynamic observation of pH change within polymer matrices for oral delivery.
    Cook MT; Saratoon T; Tzortzis G; Edwards A; Charalampopoulos D; Khutoryanskiy VV
    Biomacromolecules; 2013 Feb; 14(2):387-93. PubMed ID: 23301617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
    Xu B; Zhang W; Chen Y; Xu Y; Wang B; Zong L
    Int J Biol Macromol; 2018 Jul; 113():534-542. PubMed ID: 29408613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobic weak acid polymers as controlled release carriers.
    Cornejo-Bravo JM; Partida-Soria Y; Serrano-Medina A; Espinoza-Dueñas K; Ramos MA; Licea-Claverie A
    Pharm Dev Technol; 2012; 17(2):170-6. PubMed ID: 21047274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of pH-responsive organic-inorganic hybrid nanocomposites as an effective oral delivery system of protein drugs.
    Lee SH; Song JG; Han HK
    J Control Release; 2019 Oct; 311-312():74-84. PubMed ID: 31487499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
    Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
    Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of liposomes coated with a pH responsive polymer.
    Barea MJ; Jenkins MJ; Gaber MH; Bridson RH
    Int J Pharm; 2010 Dec; 402(1-2):89-94. PubMed ID: 20888403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery.
    Sajeesh S; Sharma CP
    J Biomed Mater Res B Appl Biomater; 2006 Feb; 76(2):298-305. PubMed ID: 16130147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an M cell targeted nanocomposite system for effective oral protein delivery: preparation, in vitro and in vivo characterization.
    Song JG; Lee SH; Han HK
    J Nanobiotechnology; 2021 Jan; 19(1):15. PubMed ID: 33422063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.